Using AI to improve outcomes for stroke patients
Trustworthy Artificial Intelligence for Improvement of Stroke Outcomes. Phase II Prospective Study for AI Models Optimization
Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06710028
This study is testing whether using AI can help doctors give better care to stroke patients and improve their recovery and long-term health.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS (other) |
| Locations | 3 sites (Leuven and 2 other locations) |
| Trial ID | NCT06710028 on ClinicalTrials.gov |
What this trial studies
This observational study aims to validate the use of explainable and interpretable Artificial Intelligence (AI) solutions in managing acute ischemic stroke. By enhancing timely and personalized care, the study seeks to reduce disability levels and improve long-term outcomes for stroke patients. It also focuses on increasing adherence to secondary stroke prevention strategies through better patient communication and engagement. The study will involve patients aged 18 and older who have been diagnosed with acute ischemic stroke.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have been diagnosed with acute ischemic stroke.
Not a fit: Patients who do not have an acute ischemic stroke diagnosis will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve recovery and quality of life for stroke patients.
How similar studies have performed: Other studies have shown promise in using AI for medical decision-making, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Subject is 18 years of age or older 2. Diagnosis of acute ischemic stroke 3. Signature of the informed consent form by the patient or a next of kin Exclusion Criteria: * No exclusion criteria are contemplated for this study.
Where this trial is running
Leuven and 2 other locations
- KATHOLIEKE UNIVERSITEIT LEUVEN (KU Leuven) — Leuven, Belgium (NOT_YET_RECRUITING)
- Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Neurologia — Rome, Lazio, Italy (RECRUITING)
- Hospital Vall D'Hebron- Institut de Recerca (Vhir) — Barcelona, Spain (RECRUITING)
Study contacts
- Principal investigator: Pietro Caliandro, MD — Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Study coordinator: Pietro Caliandro
- Email: pietro.caliandro@policlinicogemelli.it
- Phone: +390630154338
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Stroke, Acute, Stroke, Ischemic, Stroke